跳至主要内容
临床试验/IRCT20190404043159N1
IRCT20190404043159N1尚未招募2 期

The effect of duloxetine on symptoms and quality of life in patients with irritable bowel syndrome with moderate to severe symptoms

Esfahan University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Men and women aged 18 to 65 years
  • Diagnosis of irritable bowel syndrome by a gastroenterologist
  • Moderate to severe symptoms
  • Conscious consent to participate in the study
  • Have a minimum literacy
  • Absence of depressive disorders, bipolar disorder or psychotic disorders

排除标准

  • Diagnosis of any organic disease
  • Failure to take medication regularly
  • Failure to complete the questionnaire
  • Severe side effects
  • Patient request to leave the study

研究者

相似试验